This study investigated the effects of docosahexaenoicacid (DHA) supplementation on the fattyacid composition of breastmilk and plasmaconcentrations in lactatingwomen and their infants.
Eighty-nine lactatingwomen 4-6 weeks post-partum received placebo, 200mg or 400mg DHA for 6 weeks with usual diets. Breastmilkfatty acids and maternal plasmafatty acids were measured at the beginning and end of the study and infantplasma at the end of the study.
Breastmilk and maternal plasma DHA were significantly greater with 200mg and 400mg DHA compared with placebo (50% and 123% breastmilk p<0.05; 71% and 101% plasma, p<0.0001), respectively.
Infantplasmaomega6:3 and arachidonic acid (AA):DHA were significantly greater in the placebo group compared to both supplement groups (67% and 106%; 71% and 116%, respectively, p<0.05).
DHA supplementation impacts infantfatty acids important for brain development and breastmilkfattyacid composition.
Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.